Ardelyx (NASDAQ: ARDX) reported Q2 EPS of ($0.08), $0.04 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $22.3 million versus the consensus estimate of $15.28 million.

GUIDANCE:

Ardelyx currently expects full-year 2023 net product revenue for IBSRELA to be between $72.0 and $77.0 million.

For earnings history and earnings-related data on Ardelyx (ARDX) click here.